NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 323 filers reported holding NATERA INC in Q1 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $39,780,750 | +88.8% | 899,000 | +107.7% | 1.60% | +117.7% |
| Q2 2023 | $21,064,914 | +51.8% | 432,900 | +73.2% | 0.74% | +59.7% |
| Q1 2023 | $13,874,448 | -80.8% | 249,900 | -86.1% | 0.46% | -70.5% |
| Q4 2022 | $72,261,813 | -5.0% | 1,798,900 | +3.7% | 1.56% | +1.2% |
| Q3 2022 | $76,028,000 | +56.7% | 1,735,000 | +26.7% | 1.55% | +38.8% |
| Q2 2022 | $48,521,000 | -8.3% | 1,369,100 | +5.3% | 1.11% | +1.2% |
| Q1 2022 | $52,884,000 | -39.8% | 1,300,000 | +38.3% | 1.10% | -40.9% |
| Q4 2021 | $87,787,000 | +23.3% | 940,000 | +47.2% | 1.86% | +18.1% |
| Q3 2021 | $71,177,000 | +43.8% | 638,700 | +46.5% | 1.58% | +17.9% |
| Q2 2021 | $49,499,000 | +23.2% | 436,000 | +10.2% | 1.34% | +20.5% |
| Q1 2021 | $40,169,000 | -15.9% | 395,600 | -17.5% | 1.11% | -28.4% |
| Q4 2020 | $47,750,000 | +31.3% | 479,800 | -4.7% | 1.55% | -8.1% |
| Q3 2020 | $36,366,000 | – | 503,400 | – | 1.69% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |